Dry eye drops may sharpen cataract surgery outcomes

NCT ID NCT06346340

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether Miebo eye drops, used before and after cataract surgery, can improve the accuracy of lens measurements and final vision in people with dry eye. Participants apply the drops four times daily for about 30 days before surgery and again for 30 days after. The goal is to see if treating dry eye leads to better surgical outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Miebo (eye drops)
What this could lead to
If it works, this could show that treating dry eye before cataract surgery improves the accuracy of lens measurements and final vision.
What could go wrong
This is a small, open-label study, so results may be less reliable than a blinded trial. The benefit may not apply to all dry eye patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Site 101

    Somersworth, New Hampshire, 03878, United States

  • Site 102

    Petaluma, California, 92954, United States

  • Site 103

    Largo, Florida, 33770, United States

  • Site 104

    St Louis, Missouri, 63131, United States

  • Site 105

    Laguna Hills, California, 92655, United States

  • Site 106

    Oak Lawn, Illinois, 60453, United States

  • Site 107

    Sioux Falls, South Dakota, 57108, United States

  • Site 108

    Alexandria, Minnesota, 56308, United States

  • Site 109

    Sacramento, California, 94206, United States

  • Site 110

    San Antonio, Texas, 78229, United States

  • Site 111

    Grand Junction, Colorado, 81501, United States

  • Site 112

    San Antonio, Texas, 78229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.